Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

3,317 public trials 609 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

NCT01092065

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • The Parkinsons Institute Sunnyvale, California, United States
  • Colorado Neurological Institute Englewood, Colorado, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Kansas Medical Center - Parkinson's Disease and Movement Disorders Center Kansas City, Kansas, United States
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491529

Conditions
Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Novartis Investigative Site Sunnyvale, California, United States
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Novartis Investigative Site Kansas City, Kansas, United States
View all 39 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01385592

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Novartis Investigative Site Sunnyvale, California, United States
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site London, Ontario, Canada
  • Novartis Investigative Site Gatineau, Quebec, Canada
View all 28 locations
View Trial Details
Completed

Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

NCT02381444

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Universitaetsklinikum Aachen /ID# 204355 Aachen, North Rhine-Westphalia, Germany
  • Uniklinik Koln /ID# 148153 Cologne, North Rhine-Westphalia, Germany
  • Johannes Wesling Klin Minden /ID# 151481 Minden, North Rhine-Westphalia, Germany
  • KH Martha-Maria Halle Dolau /ID# 144634 Halle, Saxony-Anhalt, Germany
View all 27 locations
View Trial Details
Completed

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

NCT03624920

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • MGH Neurological Clinical Research Institute Boston, Massachusetts, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • I. neurologická klinika Fakultní nemocnice u sv. Anny Brno, Czechia
View all 34 locations
View Trial Details

Related conditions